Adjustable Cranial Orthosis (Helmets) for Infants — Coverage Criteria
Customize your policy alerts
Sign up for all blue cross blue shield - kansas policy alerts
Know when blue cross blue shield - kansas releases new policies or updates existing guidance.
Monitor payer policy activity
Policy governing medical necessity and coverage criteria for adjustable cranial orthoses used after craniosynostosis surgery and for positional plagiocephaly/brachycephaly in pediatric members of Blue Cross Blue Shield of Kansas.
No material clinical or coverage changes in this revision.
Medical Necessity and Coverage Criteria
Postoperative craniosynostosis
Covered when ALL of the following are met
Orthosis is used postoperatively to continue skull remodeling and improve symmetry; evidence consists of case series indicating benefit as postoperative adjunctive therapy.
Synostosis without surgery
This is a reason for denial if no prior cranial vault surgery has been performed.
Positional plagiocephaly or brachycephaly without synostosis
Covered when ALL of the following are met
Document age to confirm eligibility.
At least 2 months of documented unsuccessful repositioning/physical therapy is required.
Refer to Table PG1 for age- and gender-specific cephalic index threshold values.
Other indications
Devices used for indications outside postoperative synostosis or eligible plagiocephaly are noncovered.
Postsurgical cranial orthosis for craniosynostosis
Covered when criteria below are met
Document prior cranial vault surgery, surgical details, and that the orthosis is being used as postsurgical remodeling adjunct; evidence is limited to case series but considered sufficient to suggest improved outcomes in the postoperative setting.
Cranial orthosis for positional plagiocephaly (per guideline and trial evidence)
Covered when ALL of the following are met
Guideline (Congress of Neurological Surgeons) gives a level II recommendation for helmet therapy for infants with persistent moderate-to-severe plagiocephaly after conservative treatment; document severity (objective indices or Argenta classification) and prior conservative measures.
Age should be documented in prior authorization and medical record.
Evidence of failed conservative measures is required prior to helmet therapy except as otherwise clinically justified.
Report measured indices and reference the HElmet trial/Guideline when justifying therapy.
Use of an adjustable cranial orthosis is not medically necessary for indications other than postoperative craniosynostosis following cranial vault remodeling surgery or positional plagiocephaly/brachycephaly that meet the specific policy criteria. The policy specifies that helmets may be considered medically necessary only when the conditions for postsurgical use or the three criteria for nonsynostotic plagiocephaly (age 3–18 months; documented failure of ≥2 months of conservative therapy; and a cephalic index ≥2 standard deviations from the mean for age/gender) are satisfied.
Infants with very severe plagiocephaly were excluded from the HElmet randomized trial and therefore the trial does not address outcomes for very severe deformity. The trial excluded infants with an oblique diameter difference index >113% or a cranioproportional index >104%, and those thresholds define the study’s excluded (very severe) category.
The policy states that the use of an adjustable cranial orthosis is considered not medically necessary for indications not explicitly outlined in the policy. Coverage for helmet therapy is limited to the specified postsurgical and positional plagiocephaly/brachycephaly indications when all enumerated criteria are met.
Use of an adjustable cranial orthosis for craniosynostosis without prior cranial vault remodeling surgery is considered not medically necessary. Helmets are covered only as a postsurgical adjunct following cranial vault remodeling; they are not a substitute for surgical correction in synostosis.
The multicenter HElmet randomized trial (n=84) comparing helmet therapy to observation in infants with moderate-to-severe positional deformity found no significant difference in the primary 24‑month anthropometric outcomes between groups. The trial reported similar change scores for the oblique diameter difference index and cranioproportional index at 24 months (full recovery 26% orthosis vs 23% observation; odds ratio 1.2, 95% CI 0.4–3.3, p=0.74). The trial had low adherence to full-duration helmet wear (only 23% of infants in the orthosis arm wore the device until 12 months) and excluded infants with very severe deformity, which limits generalizability.
Use of an adjustable cranial orthosis is considered not medically necessary for any indications outside those explicitly enumerated in the policy (postsurgical use after cranial vault remodeling or positional plagiocephaly/brachycephaly meeting the stated age, conservative-therapy failure, and cephalic index criteria).
Regulatory & Coding Information
| FDA product code MVA | Cranial orthosis devices cleared via 510(k) |
| S1040 | Unlisted physical medicine/rehabilitation service or procedure = Cranial remolding orthotic, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s) |
| S1040 | Unlisted physical medicine/rehabilitation service or procedure = Cranial remolding orthotic, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s) |
Prior Authorization, Documentation, and Billing Actions
Prior authorization: positional plagiocephaly — age, failed conservative therapy, and cephalic index
Prior authorization must document that the infant is between 3 and 18 months of age, has failed at least 2 months of conservative therapy (repositioning and physical therapy), and has objective cephalic index measurements ≥2 standard deviations from the mean for the appropriate gender and age.
- Age: 3–18 months
- Documented failure of conservative therapy ≥2 months (repositioning and physical therapy)
- Cephalic index ≥2 SD from age/gender mean (see Table PG1)
Prior authorization: custom-fabricated cranial orthosis (S1040)
Prior authorization is required for custom-fabricated cranial remolding orthoses billed with HCPCS S1040 and must include the diagnosis, prior conservative therapy (for positional plagiocephaly) or prior cranial vault surgery (for postsurgical use), severity/measurements, patient age, and expected treatment duration.
- Include HCPCS code S1040 on the request
- Document diagnosis and prior conservative therapy trial or prior cranial vault surgery as applicable
- Provide objective severity measures (e.g., cephalic index, oblique diameter difference index) and planned helmet duration
Prior authorization implied for cranial remolding orthosis (S1040)
Requests for cranial remolding orthosis care must be prior-authorized because the policy states listed codes are medically necessary only if performed according to the Policy section; S1040 is the listed code for the custom cranial remolding orthotic.
- S1040 is the HCPCS entry for the custom pediatric rigid cranial remolding orthotic
- Inclusion of code does not itself guarantee coverage; services must meet policy criteria
Conservative therapy required before helmet therapy (minimum 2 months)
Before prescribing helmet therapy for positional plagiocephaly, document a trial of conservative therapy (repositioning and/or physical therapy) of at least 2 months' duration that has failed to correct the deformity.
- Conservative measures include repositioning and physical therapy
- Minimum documented trial duration: 2 months
Conservative therapy trial customary before orthosis; guideline context
A customary trial of conservative measures (repositioning and/or physical therapy) should be attempted prior to helmet therapy for positional plagiocephaly; guidelines support helmet use only for persistent moderate-to-severe cases after conservative treatment.
- Guideline-level recommendation: helmet therapy for persistent moderate-to-severe plagiocephaly after conservative treatment
- Conservative therapy is the usual first-line management and may lead to spontaneous correction in many infants
Documentation required for plagiocephaly coverage: age, failed conservative therapy, cephalic index
Required documentation for plagiocephaly coverage must include the patient's age to confirm they are 3–18 months old, evidence of at least 2 months' failed conservative therapy (repositioning/physical therapy), and objective cephalic index measurements showing ≥2 standard deviations from the mean for age and gender.
- Age documented (3–18 months)
- Record of conservative therapy and duration (≥2 months) and reason for failure
- Cephalic index values and reference to Table PG1 showing ≥2 SD from mean
Document conservative therapy trial and severity indices
Document the trial and failure of conservative measures (repositioning and/or physical therapy) including duration and, when applicable, objective severity indices (Argenta classification, oblique diameter difference index, or cranioproportional index) to justify helmet therapy.
- Record method(s) of conservative therapy and exact duration
- Provide severity measures (e.g., oblique diameter difference index, cranioproportional index, Argenta grade) where applicable
Postsurgical documentation: prior cranial vault surgery and intended postsurgical remodeling
For postsurgical use after craniosynostosis repair, document prior cranial vault remodeling surgery and that the orthosis is being used for postsurgical remodeling; include operative/surgeon notes, timing of surgery, and planned duration of helmet therapy.
- Include surgical details and date of cranial vault remodeling
- State that orthosis is intended as postoperative remodeling and planned helmet duration (typical ~10–12 months reported)
Billing rule: use HCPCS S1040 for custom-fabricated cranial remolding orthosis
Use HCPCS S1040 to bill for a custom-fabricated pediatric rigid cranial remolding orthotic that includes fitting and adjustments when the device is provided according to the policy's medical necessity criteria.
- S1040 description: custom fabricated pediatric rigid cranial remolding orthotic, includes fitting and adjustments
- Inclusion of the code does not itself imply coverage; device must meet Policy criteria
Denial risk: synostosis without prior cranial vault remodeling surgery
Requests for an adjustable cranial orthosis for synostosis without prior cranial vault remodeling surgery will be denied as not medically necessary.
- Synostosis without cranial vault remodeling surgery is explicitly listed as not medically necessary
Denial risk: indications outside the policy are not medically necessary
Use of an adjustable cranial orthosis for indications not enumerated in the policy (other than postoperative synostosis or plagiocephaly meeting the stated criteria) is considered not medically necessary and is a reason for denial.
- Nonenumerated indications will be reviewed as not medically necessary
Denial risk and documentation: noncompliance and early discontinuation may affect review
Track and document patient adherence and any adverse events because studies report substantial noncompliance or early discontinuation of helmet therapy (e.g., in the HElmet RCT 23% of treated infants wore the orthosis until 12 months and 10 parents discontinued due to adverse events), which may affect utilization review.
- Record adherence (hours/day and duration) and reasons for early discontinuation
- Document any adverse events reported by caregivers
Billing rule: code inclusion does not imply coverage; codes are medically necessary only if policy criteria met
Inclusion of a procedure or device code on a claim does not guarantee coverage; codes (including S1040) are medically necessary only when the service is performed in accordance with the Policy section and supporting documentation is provided.
- Submission of S1040 without meeting policy criteria may result in denial
- Verify member contract benefits in effect at time of service
Background and Rationale
Cranial orthoses are adjustable helmets or bands designed to progressively mold the infant cranium by applying corrective forces to prominent areas while leaving room for growth in flattened regions. They are used as a postsurgical adjunct following cranial vault remodeling for synostosis to continue skull remodeling, and to treat nonsynostotic positional plagiocephaly or brachycephaly by guiding cranial growth over several months of near-continuous wear.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.